Literature DB >> 10718339

F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.

D Perrin1, B van Hille, J M Barret, A Kruczynski, C Etiévant, T Imbert, B T Hill.   

Abstract

F 11782, a novel epipodophylloid, proved a potent inhibitor of the catalytic activities of both topoisomerases I and II. Unlike classical inhibitors such as camptothecin or etoposide, F 11782 did not stabilise cleavable complexes induced by either topoisomerases I or II nor did it preferentially inhibit the religation step of the catalytic cycle of either enzyme. F 11782 neither intercalated DNA nor bound in its minor groove, and showed only weak inhibition of the ATPase activity associated with topoisomerase II. F 11782 appeared to act by inhibiting the binding of topoisomerases I and II to DNA in a manner dependent both on drug and enzyme concentrations, via a mechanism not previously described or shared by other known topoisomerase 'poisons' or inhibitors. In contrast, F 11782 had only a weak effect or none at all on various other DNA-interacting enzymes. In conclusion, F 11782, as a non-intercalating, specific catalytic inhibitor of both topoisomerases I and II with an original mechanism of action, may be considered to represent the first of a new class of topoisomerase-interacting agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718339     DOI: 10.1016/s0006-2952(99)00382-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Discovery of indeno[1, 2 - c] quinoline derivatives as dual topoisomerases I/II inhibitors: part 3.

Authors:  Chih-Hua Tseng; Cherng-Chyi Tzeng; Chiao-Li Yang; Pei-Jung Lu; Yu-Peng Liu; Hui-Ling Chen; Chien-Yu Chen; Chia-Ning Yang; Yeh-Long Chen
Journal:  Mol Divers       Date:  2013-11       Impact factor: 2.943

2.  D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase IIα.

Authors:  Min Gui; Da-Kuo Shi; Min Huang; Yu Zhao; Qi-Ming Sun; Jing Zhang; Qin Chen; Jian-Ming Feng; Chun-Hong Liu; Ming Li; Ying-Xia Li; Meiyu Geng; Jian Ding
Journal:  Invest New Drugs       Date:  2010-03-25       Impact factor: 3.850

3.  Antitumor agents 294. Novel E-ring-modified camptothecin-4β-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.

Authors:  Deyong Ye; Qian Shi; Chung-Hang Leung; Seung-Whan Kim; Shin-Young Park; Elizabeth A Gullen; Zao Li Jiang; Hao Zhu; Susan L Morris-Natschke; Yung-Chi Cheng; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2012-05-19       Impact factor: 3.641

4.  Characterization of DNA-strand breakage induced in V79 cells by F 11782, a catalytic inhibitor of topoisomerases.

Authors:  J M Barret; B T Hill; P L Olive
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

5.  Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases.

Authors:  A Kruczynski; C Etiévant; D Perrin; T Imbert; F Colpaert; B T Hill
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

6.  Identification of Novel 4'-O-Demethyl-epipodophyllotoxin Derivatives as Antitumor Agents Targeting Topoisomerase II.

Authors:  Wenli Xi; Hua Sun; Kenneth F Bastow; Zhiyan Xiao; Kuo-Hsiung Lee
Journal:  Molecules       Date:  2022-08-07       Impact factor: 4.927

7.  Repair of DNA strand breaks in a minichromosome in vivo: kinetics, modeling, and effects of inhibitors.

Authors:  Slawomir Kumala; Krzysztof Fujarewicz; Dheekollu Jayaraju; Joanna Rzeszowska-Wolny; Ronald Hancock
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

8.  β-Elemene Inhibits Cell Proliferation by Regulating the Expression and Activity of Topoisomerases I and IIα in Human Hepatocarcinoma HepG-2 Cells.

Authors:  Min Gong; Ying Liu; Jian Zhang; Ya-jie Gao; Ping-ping Zhai; Xi Su; Xiang Li; Yan Li; Li Hou; Xiao-nan Cui
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.